“Efficacy and Safety of Secukinumab in the Treatment of Chronic Plaque Psoriasis: A 52-Weeks Follow up Study”. 2024. Journal of Pakistan Association of Dermatologists 34 (1): 191-99. https://doi.org/10.66344/jpad.v34i1.2545.